参考文献/References:
[1] Gleason DF. Classification of prostatic carcinomas [J]. Cancer Chemother Rep, 1966, 50(3): 125-128.
[2] Epstein JI, Allsbrook WC, Amin MB, et al. The 2005 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma [J]. Am J Surg Pathol,2005, 29(9): 1228-1242.
[3] Pierorazio PM, Walsh PC, Partin AW, et al. Prognostic gleason grade grouping: data based on the modified gleason scoring system[J]. BJU Int, 2013, 111(5): 753-760.
[4] Mckenney JK, Simko J, Bonham M, et al. The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study[J]. J Urol, 2011, 186(2): 465-469.
[5] Rodriguez-Urrego PA, Cronin AM, Al-Ahmadie HA, et al. Interobserver and intraobserver reproducibility in digital and routine microscopic assessment of prostate needle biopsies [J]. Hum Pathol, 2011, 42(1): 68-74.
[6] Ugare UG, Bassey IE, Jibrin PG, et al. Analysis of gleason grade and scores in 90 nigerian africans with prostate cancer during the period 1994 to 2004[J]. Afr Health Sci, 2012, 12(1): 69-73.
[7] Dong F, Wang C, Farris AB, et al. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system[J]. Am J Surg Pathol, 2012, 36(6): 838-843.
[8]廖利华 ,王少洪 ,沈金辉 .前列腺癌 Gleason分级系统的形成、发展和应用[J].诊断病理学杂志, 2012, 19(4): 309-312.
[9]王功伟 ,沈丹华 .国际泌尿病理协会前列腺癌 Gleason分级系统基本特征初步分析 [J].中华男科学杂志 , 2014, 20 (6): 514-517.
[10]任玉嫄,王功伟,胡浩,等.临床病理学实践中前列腺癌 Gleason评分变化趋势[J].现代肿瘤医学, 2015, 23(8): 1051-1053.
[11]马庆锋 ,王功伟 .前列腺癌 Gleason评分回顾性分析[J].中国卫生工程学, 2015, 14(2): 169-174.
[12]罗蓉 ,李麟 ,吴嘉瑜 ,等.国际泌尿病理协会前列腺癌 Gleason分级系统穿刺活检标本病理形态分析及 Gleason评分 [J].赣南医学院学报, 2015, 35(3): 361-364.
[13]贺慧杰,王功伟.前列腺癌 Gleason评分重复性初步研究 [J].中华男科学杂志, 2016, 22(1): 37-41.
[14] Epstein JI, Egevad L, Amin MB, et al. The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system [J]. Am J Surg Pathol, 2016, 40(2):244-252.
[15]田鑫 ,朱朝阳 ,李铁强 ,等.直肠超声引导下经会阴与经直肠前列腺穿刺活检术诊断前列腺癌的临床价值比较[J].中国现代医学杂志, 2014, 24(15): 80-82.
[16]魏恩.坎贝尔 -沃尔什泌尿外科学,4 [M].第 9版.北京:北京大学出版社, 2009: 63-64.
[17] Chen ME, Johnston DA, Tang K, et al. Detailed mapping of prostate carcinoma foci: biopsy strategy implications [J]. Cancer, 2000, 89(8): 1800-1809.
[18] Kassouf W, Nakanishi H, Ochiai A, et al. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies [J]. J Urol, 2007, 178(1): 111-114.
[19] Chen MK, Luo Y, Zhang H, et al. Investigation of optimal prostate biopsy schemes for Chinese patients with different clinical characteristics[J]. Urol Int, 2012, 89(4): 425-432.
[20] Hodge KK, Mcneal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate [J]. J Urol, 1989, 142(1): 66-70.
[21]蒋骁.经直肠超声造影在前列腺癌诊断和引导穿刺活检中的初步应用研究[D].苏州:苏州大学, 2013 .
[22]王佩佩.经直肠超声引导前列腺癌穿刺活检技术的应用 [J].医学综述, 2011, 17(10): 1550-1551.
[23]任全刚 ,张士祥 ,刘淑芳 ,等.经直肠超声引导下前列腺穿刺活检术对诊断前列腺癌的应用价值分析 [J].北京医学 , 2013, 35 (1): 71-72.
[24] Noguchi M, Stamey TA, Mcneal JE, et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer[J]. J Urol, 2001, 166(1): 104-109
[25] Emiliozzi P, Maymone S, Paterno A, et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy [J]. J Urol, 2004, 172(6 Pt 1): 2224-2226.
[26] Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies[J]. J Urol, 2001, 166(2): 402-410.
[27] Singh H, Canto EI, Shariat SF, et al. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy[J]. J Urol, 2004, 171(3): 1089-1092.
[28] Gore JL, Shariat SF, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer[J]. J Urol, 2001, 165(5): 1554-1559.
[29] Numao N, Kawakami S, Yokoyama M, et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy [J]. Eur Urol, 2007, 52(6): 1663-1668.
[30] Jones JS, Patel A, Sehoenfield L, et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy [J]. J Urol, 2006, 175(2): 485-488.
[31] Capitanio U, Karakiewicz PI, Valiquette L, et al. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer[J]. Urology, 2009, 73(5): 1087-1091.
[32] King CR, Mcneal JE, Gill H, et al. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients [J]. Int J Radiat Oncol Biol Phys, 2004, 59 (2): 386-391.
[33] R Hinkelammert，O Eminaga. Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients [J]. Urol Oncol, 2014, 32(4): 403-412.
[34] Chen Z, Pang J, Wang J, et al. Upgrade in gleason score between biopsy and radical prostatectomy pathology indicates poor outcomes in prostate cancer [J]. Int J Clin Exp Pathol, 2016, 9(2): 1578-1587.
[35] Ross HM, Kryvenko ON, Cowan JE, et al. Do adenocarcinomas of the prostate with gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?[J]. Am J Surg Pathol, 2012, 36(9):
[36] Khani F, Epstein JI. Prostate biopsy specimens with gleason 3+3=6 and intraductal carcinoma: radical prostatectomy findings and clinical outcomes[J]. Am J Surg Pathol, 2015, 39(10): 1383-1389.
[37] Kryvenko ON, Gupta NS, Virani N, et al. Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens [J]. Arch Pathol Lab Med, 2013, 137(5): 610-617.
[38] Kweldam CF, Wildhagen MF, Steyerberg EW, et al. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer [J]. Mod Pathol, 2015, 28(3): 457-464.
[39] Chan TY, Partin AW, Walsh PC, et al. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy[J]. Urology, 2000, 56(5): 823-827.
[40] Kang D, Fitzsimons NJ, Presti JJ, et al. Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database [J]. Urology, 2007, 70(2): 277-282. 1346-1352.
[41] Carter HB, Partin AW, Walsh PC, et al. Gleason score 6 adenocarcinoma: should it be labeled as cancer?[J]. J Clin Oncol, 2012, 30(35): 4294-4296.
[42] Loeb S, Folkvaljon Y, Robinson D, et al. Evaluation of the 2015 gleason grade groups in a nationwide population-based cohort[J]. Eur Urol, 2016, 69(6): 1135-1141.
[43] Jalloh M, Myers F, Cowan JE, et al. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics[J]. Eur Urol, 2015, 67(3): 451-457.
[44] De Cobelli O, Terracciano D, Tagliabue E, et al. Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who Met the inclusion criteria for active surveillance[J]. Urol Oncol, 2015, 33(5): 201.e1-201.e8.
[45] He B, Chen R, Gao X, et al. Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy:development and internal validation[J]. Oncotarget, 2016, 7(13): 17275-17285